Autonomix Medical, Inc.
AMIX
$2.15
-$0.18-7.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 75.50% | 284.61% | 350.00% | 310.22% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 88.10% | 227.61% | 279.41% | 275.74% | -- |
| Operating Income | -88.10% | -227.61% | -279.41% | -275.74% | -- |
| Income Before Tax | -27.64% | -73.04% | -601.57% | -675.41% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.64% | -73.04% | -601.57% | -675.41% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.64% | -73.04% | -601.57% | -675.41% | -- |
| EBIT | -88.10% | -227.61% | -279.41% | -275.74% | -- |
| EBITDA | -262.98% | -- | -- | -- | -- |
| EPS Basic | 10.49% | -18.74% | -418.45% | -480.18% | -- |
| Normalized Basic EPS | 10.49% | -18.74% | -418.44% | -480.17% | -- |
| EPS Diluted | 10.49% | -18.74% | -418.45% | -480.18% | -- |
| Normalized Diluted EPS | 10.49% | -18.74% | -418.44% | -480.17% | -- |
| Average Basic Shares Outstanding | 63.91% | 57.63% | 44.92% | 35.07% | -- |
| Average Diluted Shares Outstanding | 63.91% | 57.63% | 44.92% | 35.07% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
